ArticleBritish journal of haematology2019

Pentraxin-3 plasma levels correlate with tumour burden and overall survival in patients with primary myelofibrosis.

Ivo Veletic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.